Total Payments
$103,077
2024 Payments
$244.40
Companies
20
Transactions
198
Medicare Patients
312
Medicare Billing
$41,953
Payment Breakdown by Category
Travel$43,263 (42.0%)
Other$34,525 (33.5%)
Consulting$18,000 (17.5%)
Food & Beverage$7,289 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $43,263 | 64 | 42.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,525 | 24 | 32.5% |
| Consulting Fee | $18,000 | 8 | 17.5% |
| Food and Beverage | $7,289 | 101 | 7.1% |
| Honoraria | $1,000 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $100,601 | 146 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $484.10 | 10 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $379.85 | 13 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $212.17 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $195.78 | 4 | $0 (2024) |
| GENZYME CORPORATION | $151.68 | 2 | $0 (2019) |
| W. L. Gore & Associates, Inc. | $130.88 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $127.08 | 2 | $0 (2024) |
| Allergan Inc. | $122.33 | 1 | $0 (2018) |
| One Lambda, Inc. | $119.17 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $244.40 | 4 | One Lambda, Inc. ($119.17) |
| 2023 | $106.19 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($106.19) |
| 2022 | $1,453 | 4 | Veloxis Pharmaceuticals, Inc. ($1,351) |
| 2021 | $15,108 | 22 | Veloxis Pharmaceuticals, Inc. ($14,998) |
| 2020 | $8,620 | 20 | Veloxis Pharmaceuticals, Inc. ($8,470) |
| 2019 | $30,557 | 62 | Veloxis Pharmaceuticals, Inc. ($30,058) |
| 2018 | $21,507 | 39 | Veloxis Pharmaceuticals, Inc. ($20,920) |
| 2017 | $25,481 | 46 | Veloxis Pharmaceuticals, Inc. ($24,805) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $119.17 | General |
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $72.90 | General |
| Category: Rare Disease | ||||||
| 07/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $106.19 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2022 | KCI USA, Inc. | PREVENA (Device) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 01/16/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: Immunosuppresant | ||||||
| 01/16/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $350.72 | General |
| Category: Immunosuppresant | ||||||
| 12/16/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunosuppresant | ||||||
| 12/16/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $1,102.52 | General |
| Category: Immunosuppresant | ||||||
| 12/16/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $115.53 | General |
| Category: Immunosuppresant | ||||||
| 12/16/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $102.00 | General |
| Category: Immunosuppresant | ||||||
| 12/16/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $45.17 | General |
| Category: Immunosuppresant | ||||||
| 10/21/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $85.18 | General |
| Category: KRYSTEXXA | ||||||
| 10/19/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $540.59 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $207.19 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $118.84 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $106.00 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $44.48 | General |
| Category: Immunosuppresant | ||||||
| 09/10/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunosuppresant | ||||||
| 09/10/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $156.13 | General |
| Category: Immunosuppresant | ||||||
| 09/10/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $139.33 | General |
| Category: Immunosuppresant | ||||||
| 09/10/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $121.99 | General |
| Category: Immunosuppresant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 99 | 100 | $34,583 | $10,543 |
| 2022 | 2 | 87 | 87 | $32,342 | $12,733 |
| 2021 | 3 | 81 | 82 | $30,156 | $12,208 |
| 2020 | 2 | 45 | 45 | $15,791 | $6,469 |
Total Patients
312
Total Services
314
Medicare Billing
$41,953
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 46 | 46 | $16,836 | $5,433 | 32.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 24 | 24 | $11,160 | $3,143 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 18 | $3,204 | $991.98 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $3,383 | $974.40 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 49 | $16,268 | $7,252 | 44.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $12,090 | $4,011 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $3,984 | $1,471 | 36.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 44 | 44 | $19,712 | $7,659 | 38.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 21 | $6,636 | $3,105 | 46.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 17 | $3,808 | $1,444 | 37.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $12,383 | $4,954 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 16 | $3,408 | $1,515 | 44.4% |
About Dr. Deepak Mital, M.D
Dr. Deepak Mital, M.D is a Transplant Surgery healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720024219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Mital, M.D has received a total of $103,077 in payments from pharmaceutical and medical device companies, with $244.40 received in 2024. These payments were reported across 198 transactions from 20 companies. The most common payment nature is "Travel and Lodging" ($43,263).
As a Medicare-enrolled provider, Mital has provided services to 312 Medicare beneficiaries, totaling 314 services with total Medicare billing of $41,953. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Transplant Surgery
- Location Oak Lawn, IL
- Active Since 06/21/2006
- Last Updated 08/09/2022
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1720024219
Products in Payments
- Envarsus (Drug) $54,876
- Envarsus XR (Drug) $24,805
- Envarsus XR (SP) (Drug) $20,920
- ACTHAR (Biological) $515.54
- NULOJIX (Biological) $379.85
- SOLIRIS (Drug) $212.17
- THYMOGLOBULIN (Drug) $167.39
- PROPATEN Vascular Graft (Device) $130.88
- LIVTENCITY (Drug) $127.08
- VRAYLAR (Drug) $122.33
- JYNARQUE (Drug) $119.40
- Mitra Clip system (Device) $98.31
- MAVYRET (Drug) $96.83
- FARXIGA (Drug) $87.50
- KRYSTEXXA (Biological) $85.18
- ANDEXXA (Biological) $72.90
- LOKELMA (Drug) $35.38
- Rayaldee (Drug) $32.23
- THYMOGLOBULIN (Biological) $25.05
- LigaSure (Device) $17.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.